Latest news
Recursion Pharmaceuticals (RXRX) Director Blake Borgeson Sells 3 - GuruFocusGuruFocus · Fri, 07 Aug 2026 07:50:49 GMTRecursion Pharmaceuticals (RXRX) director sells 30,000 shares in 10b5-1 plan - Stock TitanStock Titan · Thu, 06 Aug 2026 21:10:07 GMTRecursion director Blake Borgeson disposes of 30,000 shares for $97,500 - BitgetBitget · Thu, 06 Aug 2026 13:24:57 GMT